Prosoma

Prosoma

Private
LondonHealthcare & Life Scienceshttps://prosoma.com

Last Round

Grant

Sep 9, 2025

Total Funding Raised

$7.74M

Company Overview

Prosoma is a health technology company that provides a digital therapeutics platform offering psychological and behavioral support for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Patient Engagement, Telemedicine

Business Model

B2G

Customer Profile

Government Contracts, Subscription SaaS

AI Layer

Application

Keywords

digital therapeuticsDTxpsycho-oncologycancer patient supportDiGADigital Health Applicationsprescription digital therapeuticSoftware as a Medical DeviceSaaMDprescription appCognitive Behavioral TherapyCBTcancer support appbehavioral healthmental health supportpatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prosoma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Prosoma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 9, 2025
Early FundingJan 20, 2025
Series ADec 21, 2022

Key People

Founding team and executive leadership

Andrzej Jończyk

Co-Founder, Chief Strategy Officer Head Of USA

Founding Team

Jakub Kuziela

CFO COO

Executive Team

Prosoma Investors

Notable investors and investment history

InvestorRounds
PomerangelsSeries A
YouNick MintSeries A
Impact VenturesEarly Funding
EIT HealthGrant
Smartlink PartnersEarly Funding
Verge HealthTech FundEarly Funding
RST Ventures For EarthSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2025

    Secured $586K in grant funding.

  • Jan 20, 2025

    $4.5M raised in early funding.

Prosoma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prosoma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prosoma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range37
Year Founded2017
Last FundingSep 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.